| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.87e-10 | 188 | 22 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.33e-09 | 46 | 22 | 5 | GO:0030020 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A1 COL4A2 COL4A3 KRT1 LTBP4 HSPG2 KRT4 COL18A1 COL14A1 KRT77 | 1.18e-08 | 891 | 22 | 10 | GO:0005198 |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 1.39e-05 | 43 | 22 | 3 | GO:0030280 | |
| GeneOntologyMolecularFunction | integrin binding | 9.01e-04 | 175 | 22 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | collagen binding | 3.56e-03 | 81 | 22 | 2 | GO:0005518 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 8.68e-08 | 377 | 22 | 7 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 8.84e-08 | 378 | 22 | 7 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 9.00e-08 | 379 | 22 | 7 | GO:0045229 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 2.30e-07 | 12 | 22 | 3 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 8.51e-07 | 18 | 22 | 3 | GO:0038065 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 3.42e-06 | 99 | 22 | 4 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 3.56e-06 | 100 | 22 | 4 | GO:0045103 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 4.18e-05 | 957 | 22 | 7 | GO:0097435 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 6.77e-05 | 75 | 22 | 3 | GO:0045109 | |
| GeneOntologyBiologicalProcess | circulatory system development | 7.37e-05 | 1442 | 22 | 8 | GO:0072359 | |
| GeneOntologyBiologicalProcess | angiogenesis | 7.46e-05 | 708 | 22 | 6 | GO:0001525 | |
| GeneOntologyBiologicalProcess | keratinization | 1.05e-04 | 87 | 22 | 3 | GO:0031424 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 1.64e-04 | 817 | 22 | 6 | GO:0048514 | |
| GeneOntologyBiologicalProcess | blood vessel development | 3.29e-04 | 929 | 22 | 6 | GO:0001568 | |
| GeneOntologyBiologicalProcess | vasculature development | 4.13e-04 | 969 | 22 | 6 | GO:0001944 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 6.38e-04 | 1483 | 22 | 7 | GO:0048646 | |
| GeneOntologyBiologicalProcess | negative regulation of angiogenesis | 8.21e-04 | 175 | 22 | 3 | GO:0016525 | |
| GeneOntologyBiologicalProcess | negative regulation of blood vessel morphogenesis | 8.62e-04 | 178 | 22 | 3 | GO:2000181 | |
| GeneOntologyBiologicalProcess | negative regulation of vasculature development | 8.91e-04 | 180 | 22 | 3 | GO:1901343 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 9.11e-04 | 1125 | 22 | 6 | GO:0035239 | |
| GeneOntologyBiologicalProcess | regulation of angiogenesis | 9.27e-04 | 420 | 22 | 4 | GO:0045765 | |
| GeneOntologyBiologicalProcess | regulation of vasculature development | 1.01e-03 | 430 | 22 | 4 | GO:1901342 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 1.03e-03 | 189 | 22 | 3 | GO:0030216 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell proliferation | 1.35e-03 | 208 | 22 | 3 | GO:0001936 | |
| GeneOntologyBiologicalProcess | regulation of vascular endothelial cell proliferation | 1.79e-03 | 59 | 22 | 2 | GO:1905562 | |
| GeneOntologyBiologicalProcess | vascular endothelial cell proliferation | 1.85e-03 | 60 | 22 | 2 | GO:0101023 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 1.91e-03 | 870 | 22 | 5 | GO:0030855 | |
| GeneOntologyBiologicalProcess | endothelial cell proliferation | 1.92e-03 | 235 | 22 | 3 | GO:0001935 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation | 1.95e-03 | 514 | 22 | 4 | GO:0050678 | |
| GeneOntologyBiologicalProcess | tube development | 2.83e-03 | 1402 | 22 | 6 | GO:0035295 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 2.95e-03 | 76 | 22 | 2 | GO:0030199 | |
| GeneOntologyBiologicalProcess | endothelial cell apoptotic process | 3.18e-03 | 79 | 22 | 2 | GO:0072577 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 3.28e-03 | 284 | 22 | 3 | GO:0009913 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 COL4A2 COL4A3 KRT1 LTBP4 HAPLN3 HSPG2 COL18A1 COL14A1 ANXA7 FCGBP | 1.38e-11 | 656 | 22 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 COL4A2 COL4A3 KRT1 LTBP4 HAPLN3 HSPG2 COL18A1 COL14A1 ANXA7 FCGBP | 1.42e-11 | 658 | 22 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A1 COL4A2 COL4A3 KRT1 LTBP4 HAPLN3 HSPG2 COL18A1 COL14A1 ANXA7 | 4.96e-11 | 530 | 22 | 10 | GO:0062023 |
| GeneOntologyCellularComponent | collagen type IV trimer | 2.02e-08 | 6 | 22 | 3 | GO:0005587 | |
| GeneOntologyCellularComponent | collagen trimer | 2.93e-08 | 88 | 22 | 5 | GO:0005581 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 5.65e-08 | 8 | 22 | 3 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 5.65e-08 | 8 | 22 | 3 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 5.65e-08 | 8 | 22 | 3 | GO:0098645 | |
| GeneOntologyCellularComponent | basement membrane | 1.52e-07 | 122 | 22 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.33e-06 | 21 | 22 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | keratin filament | 2.99e-06 | 97 | 22 | 4 | GO:0045095 | |
| GeneOntologyCellularComponent | supramolecular polymer | 1.65e-05 | 1187 | 22 | 8 | GO:0099081 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.07e-05 | 332 | 22 | 5 | GO:0005788 | |
| GeneOntologyCellularComponent | intermediate filament | 8.49e-05 | 227 | 22 | 4 | GO:0005882 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 1.50e-04 | 263 | 22 | 4 | GO:0045111 | |
| GeneOntologyCellularComponent | cornified envelope | 2.38e-03 | 69 | 22 | 2 | GO:0001533 | |
| GeneOntologyCellularComponent | lysosomal lumen | 4.73e-03 | 98 | 22 | 2 | GO:0043202 | |
| GeneOntologyCellularComponent | supramolecular fiber | 6.66e-03 | 1179 | 22 | 5 | GO:0099512 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 1.34e-02 | 899 | 22 | 4 | GO:0099513 | |
| GeneOntologyCellularComponent | vacuolar lumen | 1.49e-02 | 178 | 22 | 2 | GO:0005775 | |
| HumanPheno | Peripapillary atrophy | 2.69e-06 | 14 | 11 | 3 | HP:0500087 | |
| HumanPheno | Diffuse optic disc pallor | 3.36e-06 | 15 | 11 | 3 | HP:0012512 | |
| MousePheno | abnormal basement membrane morphology | 3.32e-07 | 40 | 21 | 4 | MP:0004272 | |
| MousePheno | subarachnoid hemorrhage | 1.29e-05 | 4 | 21 | 2 | MP:0031109 | |
| MousePheno | buphthalmos | 1.29e-05 | 4 | 21 | 2 | MP:0009274 | |
| MousePheno | abnormal extracellular matrix morphology | 1.34e-05 | 100 | 21 | 4 | MP:0013258 | |
| MousePheno | intracranial hemorrhage | 1.57e-05 | 104 | 21 | 4 | MP:0001915 | |
| MousePheno | anterior polar cataract | 2.14e-05 | 5 | 21 | 2 | MP:0010259 | |
| MousePheno | podocyte foot process effacement | 2.38e-05 | 38 | 21 | 3 | MP:0008140 | |
| MousePheno | irregularly shaped pupil | 2.58e-05 | 39 | 21 | 3 | MP:0001319 | |
| MousePheno | polar cataract | 3.21e-05 | 6 | 21 | 2 | MP:0010258 | |
| MousePheno | macrophthalmia | 5.99e-05 | 8 | 21 | 2 | MP:0001296 | |
| MousePheno | abnormal podocyte foot process morphology | 7.29e-05 | 55 | 21 | 3 | MP:0008059 | |
| MousePheno | abnormal podocyte morphology | 1.50e-04 | 70 | 21 | 3 | MP:0005326 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 1.50e-04 | 70 | 21 | 3 | MP:0011497 | |
| MousePheno | total cataract | 1.66e-04 | 13 | 21 | 2 | MP:0010263 | |
| MousePheno | abnormal proximal convoluted tubule morphology | 1.99e-04 | 77 | 21 | 3 | MP:0004756 | |
| MousePheno | internal hemorrhage | 2.24e-04 | 387 | 21 | 5 | MP:0001634 | |
| MousePheno | abnormal glomerular mesangium morphology | 2.49e-04 | 83 | 21 | 3 | MP:0011339 | |
| MousePheno | abnormal pupil morphology | 2.67e-04 | 85 | 21 | 3 | MP:0001317 | |
| MousePheno | abnormal renal tubule morphology | 3.26e-04 | 227 | 21 | 4 | MP:0002703 | |
| MousePheno | hemorrhage | 3.30e-04 | 664 | 21 | 6 | MP:0001914 | |
| MousePheno | hematuria | 3.62e-04 | 19 | 21 | 2 | MP:0005161 | |
| MousePheno | lens vacuoles | 4.02e-04 | 20 | 21 | 2 | MP:0011697 | |
| MousePheno | abnormal renal glomerular capsule morphology | 5.25e-04 | 107 | 21 | 3 | MP:0002828 | |
| MousePheno | postnatal lethality | 7.30e-04 | 1084 | 21 | 7 | MP:0002082 | |
| MousePheno | abnormal left lung morphology | 7.94e-04 | 28 | 21 | 2 | MP:0009569 | |
| MousePheno | abnormal skin physiology | 8.01e-04 | 288 | 21 | 4 | MP:0005501 | |
| MousePheno | abnormal heart ventricle morphology | 8.50e-04 | 793 | 21 | 6 | MP:0005294 | |
| MousePheno | increased effector memory T-helper cell number | 8.52e-04 | 29 | 21 | 2 | MP:0013772 | |
| MousePheno | abnormal blood vessel morphology | 8.57e-04 | 1472 | 21 | 8 | MP:0001614 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | 9.07e-04 | 1124 | 21 | 7 | MP:0011112 | |
| MousePheno | renal cast | 1.17e-03 | 34 | 21 | 2 | MP:0011402 | |
| MousePheno | abnormal blood circulation | 1.19e-03 | 845 | 21 | 6 | MP:0002128 | |
| MousePheno | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | 1.31e-03 | 36 | 21 | 2 | MP:0010168 | |
| MousePheno | abnormal ion homeostasis | 1.56e-03 | 1232 | 21 | 7 | MP:0001765 | |
| Domain | C4 | 2.83e-08 | 6 | 22 | 3 | SM00111 | |
| Domain | - | 2.83e-08 | 6 | 22 | 3 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.83e-08 | 6 | 22 | 3 | IPR001442 | |
| Domain | NC1_IV | 2.83e-08 | 6 | 22 | 3 | PS51403 | |
| Domain | C4 | 2.83e-08 | 6 | 22 | 3 | PF01413 | |
| Domain | Collagen | 4.29e-08 | 85 | 22 | 5 | PF01391 | |
| Domain | Collagen | 4.29e-08 | 85 | 22 | 5 | IPR008160 | |
| Domain | CTDL_fold | 1.37e-07 | 107 | 22 | 5 | IPR016187 | |
| Domain | Keratin_II | 3.62e-06 | 26 | 22 | 3 | IPR003054 | |
| Domain | Keratin_I | 1.82e-05 | 44 | 22 | 3 | IPR002957 | |
| Domain | Laminin_G | 4.20e-05 | 58 | 22 | 3 | IPR001791 | |
| Domain | Intermediate_filament_CS | 5.38e-05 | 63 | 22 | 3 | IPR018039 | |
| Domain | IF | 8.03e-05 | 72 | 22 | 3 | PS00226 | |
| Domain | Filament | 8.36e-05 | 73 | 22 | 3 | PF00038 | |
| Domain | GrpE_coiled_coil | 8.68e-05 | 12 | 22 | 2 | IPR013805 | |
| Domain | IF | 9.43e-05 | 76 | 22 | 3 | IPR001664 | |
| Domain | TSPN | 3.30e-04 | 23 | 22 | 2 | SM00210 | |
| Domain | Keratin_2_head | 3.60e-04 | 24 | 22 | 2 | IPR032444 | |
| Domain | Keratin_2_head | 3.60e-04 | 24 | 22 | 2 | PF16208 | |
| Domain | LamG | 1.22e-03 | 44 | 22 | 2 | SM00282 | |
| Domain | ConA-like_dom | 2.08e-03 | 219 | 22 | 3 | IPR013320 | |
| Domain | EGF | 2.54e-03 | 235 | 22 | 3 | SM00181 | |
| Domain | EGF-like_dom | 2.99e-03 | 249 | 22 | 3 | IPR000742 | |
| Domain | Filament | 3.13e-03 | 71 | 22 | 2 | SM01391 | |
| Domain | Prefoldin | 3.22e-03 | 72 | 22 | 2 | IPR009053 | |
| Domain | IGv | 3.49e-03 | 75 | 22 | 2 | SM00406 | |
| Domain | - | 5.76e-03 | 97 | 22 | 2 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 6.00e-03 | 99 | 22 | 2 | IPR016186 | |
| Domain | EGF_CA | 8.98e-03 | 122 | 22 | 2 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 9.26e-03 | 124 | 22 | 2 | IPR001881 | |
| Domain | Growth_fac_rcpt_ | 1.44e-02 | 156 | 22 | 2 | IPR009030 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 9.10e-11 | 30 | 15 | 5 | M27216 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 4.75e-10 | 41 | 15 | 5 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 6.87e-10 | 44 | 15 | 5 | M27812 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.34e-09 | 50 | 15 | 5 | MM14796 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.73e-09 | 61 | 15 | 5 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.73e-09 | 61 | 15 | 5 | MM14637 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.01e-09 | 140 | 15 | 6 | M587 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.77e-09 | 64 | 15 | 5 | M26953 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 6.03e-09 | 67 | 15 | 5 | M26999 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.03e-08 | 300 | 15 | 7 | M610 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.15e-08 | 76 | 15 | 5 | MM14573 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.03e-08 | 85 | 15 | 5 | M16441 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.71e-08 | 90 | 15 | 5 | M631 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.16e-07 | 10 | 15 | 3 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.16e-07 | 10 | 15 | 3 | MM1560 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.55e-07 | 258 | 15 | 6 | MM14572 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.60e-07 | 11 | 15 | 3 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.13e-07 | 12 | 15 | 3 | MM1526 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.36e-07 | 53 | 15 | 4 | MM14566 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.77e-07 | 13 | 15 | 3 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.77e-07 | 13 | 15 | 3 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.52e-07 | 14 | 15 | 3 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.52e-07 | 14 | 15 | 3 | M6487 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.65e-07 | 59 | 15 | 4 | M27218 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 4.40e-07 | 15 | 15 | 3 | M27161 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.40e-07 | 15 | 15 | 3 | MM14922 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.88e-07 | 18 | 15 | 3 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.88e-07 | 18 | 15 | 3 | MM14882 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.02e-06 | 76 | 15 | 4 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.02e-06 | 76 | 15 | 4 | MM14867 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.10e-06 | 20 | 15 | 3 | M15394 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.10e-06 | 20 | 15 | 3 | MM15061 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.70e-06 | 23 | 15 | 3 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.70e-06 | 23 | 15 | 3 | MM1427 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.75e-06 | 32 | 15 | 3 | MM14924 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.17e-06 | 114 | 15 | 4 | MM14571 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 7.53e-06 | 502 | 15 | 6 | MM14537 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 8.04e-06 | 38 | 15 | 3 | MM14969 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.09e-05 | 42 | 15 | 3 | M7169 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.44e-05 | 46 | 15 | 3 | M198 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.76e-05 | 57 | 15 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.90e-05 | 58 | 15 | 3 | M2049 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.73e-05 | 63 | 15 | 3 | M11187 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.28e-05 | 66 | 15 | 3 | M18 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 6.04e-05 | 74 | 15 | 3 | M160 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 8.82e-05 | 84 | 15 | 3 | M7098 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 9.79e-05 | 87 | 15 | 3 | MM15351 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.31e-04 | 96 | 15 | 3 | M39834 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.79e-04 | 19 | 15 | 2 | M27221 | |
| Pathway | REACTOME_HS_GAG_DEGRADATION | 2.88e-04 | 24 | 15 | 2 | M636 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 3.14e-04 | 129 | 15 | 3 | M27649 | |
| Pathway | REACTOME_KERATINIZATION | 5.18e-04 | 153 | 15 | 3 | MM15343 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 6.01e-04 | 161 | 15 | 3 | M39770 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 9.31e-04 | 43 | 15 | 2 | M39565 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 9.31e-04 | 43 | 15 | 2 | M53 | |
| Pathway | REACTOME_KERATINIZATION | 1.43e-03 | 217 | 15 | 3 | M27640 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 1.63e-03 | 57 | 15 | 2 | M692 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.42e-03 | 261 | 15 | 3 | MM15676 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 2.42e-03 | 1432 | 15 | 6 | M509 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 3.20e-03 | 288 | 15 | 3 | M16864 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 3.50e-03 | 84 | 15 | 2 | M3228 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 4.74e-03 | 98 | 15 | 2 | M27152 | |
| Pathway | WP_PI3KAKT_SIGNALING | 5.06e-03 | 339 | 15 | 3 | M39736 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 7.71e-03 | 126 | 15 | 2 | M695 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 9.03e-03 | 418 | 15 | 3 | MM15587 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 1.03e-02 | 439 | 15 | 3 | M42563 | |
| Pathway | WP_CANCER_PATHWAYS | 1.52e-02 | 507 | 15 | 3 | M48302 | |
| Pathway | WP_FOCAL_ADHESION | 1.64e-02 | 187 | 15 | 2 | MM15913 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.73e-02 | 532 | 15 | 3 | M27870 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.84e-02 | 199 | 15 | 2 | M7253 | |
| Pathway | WP_FOCAL_ADHESION | 1.84e-02 | 199 | 15 | 2 | M39402 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.13e-02 | 575 | 15 | 3 | M29853 | |
| Pubmed | 3.54e-14 | 153 | 22 | 8 | 25037231 | ||
| Pubmed | 1.05e-13 | 175 | 22 | 8 | 28071719 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.84e-12 | 135 | 22 | 7 | 28675934 | |
| Pubmed | 8.32e-12 | 167 | 22 | 7 | 22159717 | ||
| Pubmed | 2.51e-11 | 10 | 22 | 4 | 9136074 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 3.95e-11 | 11 | 22 | 4 | 7500359 | |
| Pubmed | 5.92e-11 | 12 | 22 | 4 | 16024816 | ||
| Pubmed | 1.29e-10 | 50 | 22 | 5 | 23658023 | ||
| Pubmed | 1.63e-10 | 15 | 22 | 4 | 9264260 | ||
| Pubmed | 2.17e-10 | 16 | 22 | 4 | 15878328 | ||
| Pubmed | 2.20e-10 | 3 | 22 | 3 | 3025878 | ||
| Pubmed | 3.48e-10 | 146 | 22 | 6 | 27068509 | ||
| Pubmed | 4.62e-10 | 64 | 22 | 5 | 22261194 | ||
| Pubmed | 7.13e-10 | 21 | 22 | 4 | 27856617 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 8.78e-10 | 4 | 22 | 3 | 7827955 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.36e-09 | 79 | 22 | 5 | 18757743 | |
| Pubmed | 2.19e-09 | 5 | 22 | 3 | 9524110 | ||
| Pubmed | 2.19e-09 | 5 | 22 | 3 | 9409248 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 3.86e-09 | 97 | 22 | 5 | 27559042 | |
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 4.39e-09 | 6 | 22 | 3 | 10534397 | |
| Pubmed | 4.39e-09 | 6 | 22 | 3 | 16041630 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 4.39e-09 | 6 | 22 | 3 | 9506531 | |
| Pubmed | 4.39e-09 | 6 | 22 | 3 | 7495302 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 4.39e-09 | 6 | 22 | 3 | 9673377 | |
| Pubmed | 4.39e-09 | 6 | 22 | 3 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 4.39e-09 | 6 | 22 | 3 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 4.39e-09 | 6 | 22 | 3 | 6811420 | |
| Pubmed | 4.39e-09 | 6 | 22 | 3 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 4.39e-09 | 6 | 22 | 3 | 19275937 | |
| Pubmed | 4.39e-09 | 6 | 22 | 3 | 6988303 | ||
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 4.39e-09 | 6 | 22 | 3 | 6389236 | |
| Pubmed | 4.39e-09 | 6 | 22 | 3 | 12225806 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 4.73e-09 | 101 | 22 | 5 | 20551380 | |
| Pubmed | Large-scale identification of genes implicated in kidney glomerulus development and function. | 5.50e-09 | 34 | 22 | 4 | 16498405 | |
| Pubmed | Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice. | 7.68e-09 | 7 | 22 | 3 | 15377789 | |
| Pubmed | 7.68e-09 | 7 | 22 | 3 | 10639489 | ||
| Pubmed | 7.68e-09 | 7 | 22 | 3 | 7521231 | ||
| Pubmed | 7.68e-09 | 7 | 22 | 3 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 7.68e-09 | 7 | 22 | 3 | 8006028 | |
| Pubmed | 7.68e-09 | 7 | 22 | 3 | 10416788 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 7.68e-09 | 7 | 22 | 3 | 10716744 | |
| Pubmed | 7.68e-09 | 7 | 22 | 3 | 1724753 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 8.39e-09 | 248 | 22 | 6 | 24006456 | |
| Pubmed | 9.73e-09 | 39 | 22 | 4 | 33580754 | ||
| Pubmed | 1.23e-08 | 8 | 22 | 3 | 10382266 | ||
| Pubmed | 1.23e-08 | 8 | 22 | 3 | 3997552 | ||
| Pubmed | 1.23e-08 | 8 | 22 | 3 | 29422532 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 1.23e-08 | 8 | 22 | 3 | 10970885 | |
| Pubmed | 1.23e-08 | 8 | 22 | 3 | 1383086 | ||
| Pubmed | 1.23e-08 | 8 | 22 | 3 | 1377218 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 1.23e-08 | 8 | 22 | 3 | 11867580 | |
| Pubmed | 1.84e-08 | 9 | 22 | 3 | 9878537 | ||
| Pubmed | 1.84e-08 | 9 | 22 | 3 | 17330888 | ||
| Pubmed | 1.84e-08 | 9 | 22 | 3 | 8562707 | ||
| Pubmed | 1.84e-08 | 9 | 22 | 3 | 12101409 | ||
| Pubmed | 1.84e-08 | 9 | 22 | 3 | 10880400 | ||
| Pubmed | 1.84e-08 | 9 | 22 | 3 | 8995276 | ||
| Pubmed | Generation of a conditionally null allele of the laminin alpha1 gene. | 2.63e-08 | 10 | 22 | 3 | 16100707 | |
| Pubmed | 2.63e-08 | 10 | 22 | 3 | 9415455 | ||
| Pubmed | Interaction of hydroxylated collagen IV with the von hippel-lindau tumor suppressor. | 3.61e-08 | 11 | 22 | 3 | 17339318 | |
| Pubmed | 3.61e-08 | 11 | 22 | 3 | 14998921 | ||
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 3.61e-08 | 11 | 22 | 3 | 9731539 | |
| Pubmed | 4.81e-08 | 12 | 22 | 3 | 8918877 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 4.81e-08 | 12 | 22 | 3 | 15837576 | |
| Pubmed | 4.81e-08 | 12 | 22 | 3 | 26794322 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 4.81e-08 | 12 | 22 | 3 | 12180907 | |
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 6.26e-08 | 13 | 22 | 3 | 9833687 | |
| Pubmed | Membrane-type MMPs are indispensable for placental labyrinth formation and development. | 7.96e-08 | 14 | 22 | 3 | 20858856 | |
| Pubmed | 7.96e-08 | 14 | 22 | 3 | 12878203 | ||
| Pubmed | 9.95e-08 | 15 | 22 | 3 | 10625553 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 9.95e-08 | 15 | 22 | 3 | 10706142 | |
| Pubmed | 9.95e-08 | 15 | 22 | 3 | 38103869 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 1.70e-07 | 1070 | 22 | 8 | 23533145 | |
| Pubmed | 1.78e-07 | 18 | 22 | 3 | 9160753 | ||
| Pubmed | 1.93e-07 | 81 | 22 | 4 | 39217171 | ||
| Pubmed | 2.11e-07 | 19 | 22 | 3 | 15689378 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.46e-07 | 86 | 22 | 4 | 28327460 | |
| Pubmed | 2.90e-07 | 21 | 22 | 3 | 23325811 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 3597383 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 17179069 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 3200851 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 32515830 | ||
| Pubmed | Sequence variants in COL4A1 and COL4A2 genes in Ecuadorian families with keratoconus. | 3.82e-07 | 2 | 22 | 2 | 21527998 | |
| Pubmed | COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. | 3.82e-07 | 2 | 22 | 2 | 22209247 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 39216230 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 22914737 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 24317722 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 31331924 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 26006016 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 30351356 | ||
| Pubmed | Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. | 3.82e-07 | 2 | 22 | 2 | 15905400 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 24203695 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 3198626 | ||
| Pubmed | Intracerebral hemorrhage in a neonate with an intragenic COL4A2 duplication. | 3.82e-07 | 2 | 22 | 2 | 33247988 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 32413593 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 11970952 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 1630813 | ||
| Pubmed | Further refinement of COL4A1 and COL4A2 related cortical malformations. | 3.82e-07 | 2 | 22 | 2 | 30315939 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 26209635 | ||
| Pubmed | Prenatal clinical manifestations in individuals with COL4A1/2 variants. | 3.82e-07 | 2 | 22 | 2 | 32732225 | |
| Interaction | FBLN2 interactions | 8.14e-09 | 66 | 22 | 5 | int:FBLN2 | |
| Interaction | MMP9 interactions | 8.79e-09 | 67 | 22 | 5 | int:MMP9 | |
| Interaction | C1QTNF1 interactions | 1.84e-07 | 47 | 22 | 4 | int:C1QTNF1 | |
| Interaction | LAIR2 interactions | 2.18e-07 | 49 | 22 | 4 | int:LAIR2 | |
| Interaction | HABP2 interactions | 9.12e-07 | 18 | 22 | 3 | int:HABP2 | |
| Interaction | OSM interactions | 1.27e-06 | 20 | 22 | 3 | int:OSM | |
| Interaction | MMP2 interactions | 2.23e-06 | 87 | 22 | 4 | int:MMP2 | |
| Interaction | TGFBI interactions | 2.56e-06 | 25 | 22 | 3 | int:TGFBI | |
| Interaction | BGN interactions | 4.50e-06 | 30 | 22 | 3 | int:BGN | |
| Interaction | PDGFA interactions | 5.49e-06 | 32 | 22 | 3 | int:PDGFA | |
| Interaction | KRT25 interactions | 7.22e-06 | 35 | 22 | 3 | int:KRT25 | |
| Interaction | C1QTNF9 interactions | 8.56e-06 | 37 | 22 | 3 | int:C1QTNF9 | |
| Interaction | TMEM25 interactions | 1.25e-05 | 134 | 22 | 4 | int:TMEM25 | |
| Interaction | C1QC interactions | 1.26e-05 | 42 | 22 | 3 | int:C1QC | |
| Interaction | COL8A2 interactions | 1.26e-05 | 42 | 22 | 3 | int:COL8A2 | |
| Interaction | DCN interactions | 1.35e-05 | 43 | 22 | 3 | int:DCN | |
| Interaction | FGF4 interactions | 1.45e-05 | 44 | 22 | 3 | int:FGF4 | |
| Interaction | CD93 interactions | 1.56e-05 | 45 | 22 | 3 | int:CD93 | |
| Interaction | COL4A1 interactions | 1.89e-05 | 48 | 22 | 3 | int:COL4A1 | |
| Interaction | NID1 interactions | 1.89e-05 | 48 | 22 | 3 | int:NID1 | |
| Interaction | SAA1 interactions | 2.70e-05 | 54 | 22 | 3 | int:SAA1 | |
| Interaction | SERPINE2 interactions | 3.01e-05 | 56 | 22 | 3 | int:SERPINE2 | |
| Interaction | BMP3 interactions | 3.17e-05 | 8 | 22 | 2 | int:BMP3 | |
| Interaction | COL21A1 interactions | 4.08e-05 | 9 | 22 | 2 | int:COL21A1 | |
| Interaction | COLGALT2 interactions | 5.17e-05 | 67 | 22 | 3 | int:COLGALT2 | |
| Interaction | KRT36 interactions | 6.96e-05 | 74 | 22 | 3 | int:KRT36 | |
| Interaction | COL4A2 interactions | 7.25e-05 | 75 | 22 | 3 | int:COL4A2 | |
| Interaction | RNF208 interactions | 7.25e-05 | 75 | 22 | 3 | int:RNF208 | |
| Interaction | KRT33B interactions | 1.37e-04 | 93 | 22 | 3 | int:KRT33B | |
| Interaction | HSPG2 interactions | 1.61e-04 | 98 | 22 | 3 | int:HSPG2 | |
| Interaction | COL18A1 interactions | 1.61e-04 | 98 | 22 | 3 | int:COL18A1 | |
| Interaction | KRT19 interactions | 2.25e-04 | 282 | 22 | 4 | int:KRT19 | |
| Interaction | KRT35 interactions | 2.32e-04 | 111 | 22 | 3 | int:KRT35 | |
| Interaction | PRG2 interactions | 2.34e-04 | 285 | 22 | 4 | int:PRG2 | |
| Interaction | SAXO5 interactions | 2.36e-04 | 21 | 22 | 2 | int:SAXO5 | |
| Interaction | MATN2 interactions | 2.45e-04 | 113 | 22 | 3 | int:MATN2 | |
| Interaction | PLOD1 interactions | 2.57e-04 | 292 | 22 | 4 | int:PLOD1 | |
| Interaction | FBLN1 interactions | 3.61e-04 | 129 | 22 | 3 | int:FBLN1 | |
| Interaction | P4HA2 interactions | 4.40e-04 | 138 | 22 | 3 | int:P4HA2 | |
| Interaction | ANTXR2 interactions | 4.54e-04 | 29 | 22 | 2 | int:ANTXR2 | |
| Interaction | KRT28 interactions | 4.86e-04 | 30 | 22 | 2 | int:KRT28 | |
| Interaction | COL4A3 interactions | 4.86e-04 | 30 | 22 | 2 | int:COL4A3 | |
| Interaction | PRELP interactions | 5.53e-04 | 32 | 22 | 2 | int:PRELP | |
| Interaction | COLQ interactions | 5.88e-04 | 33 | 22 | 2 | int:COLQ | |
| Interaction | KRT26 interactions | 6.62e-04 | 35 | 22 | 2 | int:KRT26 | |
| Interaction | SFTPA2 interactions | 7.81e-04 | 38 | 22 | 2 | int:SFTPA2 | |
| Interaction | ZUP1 interactions | 8.63e-04 | 174 | 22 | 3 | int:ZUP1 | |
| Interaction | KRT15 interactions | 9.22e-04 | 178 | 22 | 3 | int:KRT15 | |
| Interaction | CCL3 interactions | 9.22e-04 | 178 | 22 | 3 | int:CCL3 | |
| Interaction | FBXO2 interactions | 9.32e-04 | 411 | 22 | 4 | int:FBXO2 | |
| Interaction | NPHP3 interactions | 9.54e-04 | 42 | 22 | 2 | int:NPHP3 | |
| Interaction | PLOD3 interactions | 9.99e-04 | 183 | 22 | 3 | int:PLOD3 | |
| Interaction | KRT18 interactions | 1.00e-03 | 419 | 22 | 4 | int:KRT18 | |
| Interaction | KRT14 interactions | 1.15e-03 | 192 | 22 | 3 | int:KRT14 | |
| Interaction | WTAP interactions | 1.18e-03 | 194 | 22 | 3 | int:WTAP | |
| Interaction | KRT16 interactions | 1.24e-03 | 197 | 22 | 3 | int:KRT16 | |
| Interaction | ODAPH interactions | 1.30e-03 | 49 | 22 | 2 | int:ODAPH | |
| Interaction | KRT27 interactions | 1.33e-03 | 202 | 22 | 3 | int:KRT27 | |
| Interaction | C1QTNF9B interactions | 1.40e-03 | 51 | 22 | 2 | int:C1QTNF9B | |
| Interaction | KRT24 interactions | 1.57e-03 | 54 | 22 | 2 | int:KRT24 | |
| Interaction | ITLN2 interactions | 1.87e-03 | 59 | 22 | 2 | int:ITLN2 | |
| Interaction | FN1 interactions | 1.89e-03 | 848 | 22 | 5 | int:FN1 | |
| Interaction | C1QTNF2 interactions | 2.07e-03 | 62 | 22 | 2 | int:C1QTNF2 | |
| Interaction | KRT2 interactions | 2.07e-03 | 236 | 22 | 3 | int:KRT2 | |
| Interaction | GDF9 interactions | 2.20e-03 | 64 | 22 | 2 | int:GDF9 | |
| Interaction | SPARC interactions | 2.27e-03 | 65 | 22 | 2 | int:SPARC | |
| Interaction | LAMA1 interactions | 2.34e-03 | 66 | 22 | 2 | int:LAMA1 | |
| Interaction | C1QTNF7 interactions | 2.55e-03 | 69 | 22 | 2 | int:C1QTNF7 | |
| Interaction | LGR4 interactions | 2.79e-03 | 262 | 22 | 3 | int:LGR4 | |
| Interaction | C1QL4 interactions | 2.85e-03 | 73 | 22 | 2 | int:C1QL4 | |
| Interaction | METTL14 interactions | 2.86e-03 | 558 | 22 | 4 | int:METTL14 | |
| Interaction | FGL1 interactions | 3.17e-03 | 77 | 22 | 2 | int:FGL1 | |
| Interaction | CRP interactions | 3.17e-03 | 77 | 22 | 2 | int:CRP | |
| Interaction | KRT7 interactions | 3.41e-03 | 80 | 22 | 2 | int:KRT7 | |
| Interaction | KRT34 interactions | 3.46e-03 | 283 | 22 | 3 | int:KRT34 | |
| Cytoband | 12q13.13 | 4.48e-06 | 67 | 22 | 3 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 4.56e-05 | 423 | 22 | 4 | chr12q13 | |
| Cytoband | 13q34 | 3.09e-04 | 54 | 22 | 2 | 13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q34 | 8.18e-04 | 88 | 22 | 2 | chr13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q24 | 1.24e-02 | 355 | 22 | 2 | chr8q24 | |
| GeneFamily | Collagens | 3.64e-10 | 46 | 16 | 5 | 490 | |
| GeneFamily | Keratins, type II | 1.64e-06 | 27 | 16 | 3 | 609 | |
| Coexpression | NABA_CORE_MATRISOME | 3.23e-11 | 270 | 22 | 8 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 3.73e-11 | 275 | 22 | 8 | M5884 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.65e-10 | 40 | 22 | 5 | M5887 | |
| Coexpression | NABA_COLLAGENS | 2.41e-10 | 43 | 22 | 5 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 2.72e-10 | 44 | 22 | 5 | M3005 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 3.26e-09 | 23 | 22 | 4 | M48001 | |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A2 COL4A3 LTBP4 HAPLN3 HSPG2 COL18A1 COL14A1 ANXA7 | 5.62e-08 | 1008 | 22 | 9 | MM17056 |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A2 COL4A3 LTBP4 HAPLN3 HSPG2 COL18A1 COL14A1 ANXA7 | 6.54e-08 | 1026 | 22 | 9 | M5889 |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 2.32e-07 | 15 | 22 | 3 | MM402 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 5.01e-07 | 194 | 22 | 5 | M39122 | |
| Coexpression | GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN | 5.83e-07 | 200 | 22 | 5 | M8220 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.10e-06 | 479 | 22 | 6 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.20e-06 | 483 | 22 | 6 | MM1082 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 2.48e-06 | 493 | 22 | 6 | M19391 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 2.75e-06 | 33 | 22 | 3 | M9167 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 3.30e-06 | 35 | 22 | 3 | MM17054 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 7.14e-06 | 151 | 22 | 4 | M8901 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 7.50e-06 | 337 | 22 | 5 | MM16606 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 8.33e-06 | 157 | 22 | 4 | MM1099 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 9.66e-06 | 163 | 22 | 4 | M12112 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_BRAIN_LUNG_LIVER_METASTASTASES_TUMOR_CELL_DERIVED | 1.41e-05 | 7 | 22 | 2 | M48003 | |
| Coexpression | GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_UP | 2.16e-05 | 200 | 22 | 4 | M8205 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 2.48e-05 | 68 | 22 | 3 | M1373 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 2.95e-05 | 72 | 22 | 3 | MM1131 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 3.89e-05 | 79 | 22 | 3 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 4.04e-05 | 80 | 22 | 3 | MM1285 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 4.51e-05 | 83 | 22 | 3 | M2448 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 5.02e-05 | 86 | 22 | 3 | M2259 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_BRAIN_LIVER_LUNG_METASTASTASES | 5.22e-05 | 13 | 22 | 2 | M48004 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 6.55e-05 | 94 | 22 | 3 | M2580 | |
| Coexpression | ROZANOV_MMP14_TARGETS_UP | 6.66e-05 | 267 | 22 | 4 | M12890 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 6.76e-05 | 95 | 22 | 3 | MM1328 | |
| Coexpression | DESCARTES_ORGANOGENESIS_ENDOTHELIAL_CELLS | 7.16e-05 | 272 | 22 | 4 | MM3634 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL | 7.19e-05 | 97 | 22 | 3 | M45794 | |
| Coexpression | TRAVAGLINI_LUNG_BASOPHIL_MAST_1_CELL | 7.58e-05 | 276 | 22 | 4 | M41689 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B | 8.10e-05 | 554 | 22 | 5 | M2244 | |
| Coexpression | MENON_FETAL_KIDNEY_9_ENDOTHELIAL_CELLS | 8.35e-05 | 102 | 22 | 3 | M39259 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 8.35e-05 | 102 | 22 | 3 | MM1064 | |
| Coexpression | KANG_AR_TARGETS_UP | 9.08e-05 | 17 | 22 | 2 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 9.08e-05 | 17 | 22 | 2 | MM1297 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 1.31e-04 | 318 | 22 | 4 | M41707 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_ENDOTHELIAL_CELLS | 2.00e-04 | 137 | 22 | 3 | M41743 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 2.22e-04 | 365 | 22 | 4 | M39018 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 2.88e-04 | 155 | 22 | 3 | M39246 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL | 2.88e-04 | 391 | 22 | 4 | M41659 | |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_UP | 3.08e-04 | 398 | 22 | 4 | M4872 | |
| Coexpression | MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN | 3.10e-04 | 159 | 22 | 3 | M38979 | |
| Coexpression | MULLIGHAN_NPM1_SIGNATURE_3_DN | 3.21e-04 | 161 | 22 | 3 | M15047 | |
| Coexpression | MA_RAT_AGING_DN | 3.21e-04 | 161 | 22 | 3 | M46419 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 3.27e-04 | 162 | 22 | 3 | M45037 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 3.52e-04 | 166 | 22 | 3 | M1542 | |
| Coexpression | MA_RAT_AGING_DN | 3.77e-04 | 170 | 22 | 3 | MM16097 | |
| Coexpression | NABA_PROTEOGLYCANS | 3.93e-04 | 35 | 22 | 2 | M5882 | |
| Coexpression | NABA_PROTEOGLYCANS | 4.16e-04 | 36 | 22 | 2 | MM17061 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 4.17e-04 | 176 | 22 | 3 | M39223 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS | 4.38e-04 | 179 | 22 | 3 | M41745 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 4.38e-04 | 179 | 22 | 3 | MM660 | |
| Coexpression | HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN | 4.40e-04 | 37 | 22 | 2 | M41058 | |
| Coexpression | WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN | 4.40e-04 | 37 | 22 | 2 | M16944 | |
| Coexpression | WU_CELL_MIGRATION | 4.68e-04 | 183 | 22 | 3 | M2001 | |
| Coexpression | CYCLIN_D1_UP.V1_UP | 4.98e-04 | 187 | 22 | 3 | M2654 | |
| Coexpression | CUI_DEVELOPING_HEART_CORONARY_VASCULAR_ENDOTHELIAL_CELL | 5.41e-04 | 41 | 22 | 2 | M39320 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 5.46e-04 | 193 | 22 | 3 | M39321 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_AT1_CELL | 5.67e-04 | 42 | 22 | 2 | M45688 | |
| Coexpression | GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN | 5.97e-04 | 199 | 22 | 3 | M8197 | |
| Coexpression | GSE43955_1H_VS_60H_ACT_CD4_TCELL_DN | 5.97e-04 | 199 | 22 | 3 | M9651 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_DN | 6.06e-04 | 200 | 22 | 3 | M3734 | |
| Coexpression | GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP | 6.06e-04 | 200 | 22 | 3 | M8328 | |
| Coexpression | GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 6.06e-04 | 200 | 22 | 3 | M9687 | |
| Coexpression | GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 6.06e-04 | 200 | 22 | 3 | M9675 | |
| Coexpression | GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_DN | 6.06e-04 | 200 | 22 | 3 | M8833 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN | 6.06e-04 | 200 | 22 | 3 | M6617 | |
| Coexpression | GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP | 6.06e-04 | 200 | 22 | 3 | M8203 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN | 6.06e-04 | 200 | 22 | 3 | M8688 | |
| Coexpression | HALLMARK_KRAS_SIGNALING_DN | 6.06e-04 | 200 | 22 | 3 | M5956 | |
| Coexpression | GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP | 6.06e-04 | 200 | 22 | 3 | M7802 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 6.23e-04 | 44 | 22 | 2 | M18274 | |
| Coexpression | MANALO_HYPOXIA_UP | 6.51e-04 | 205 | 22 | 3 | M259 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 6.51e-04 | 45 | 22 | 2 | M1605 | |
| Coexpression | MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN | 6.69e-04 | 207 | 22 | 3 | M38977 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 6.81e-04 | 46 | 22 | 2 | MM1187 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 6.81e-04 | 46 | 22 | 2 | MM544 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 7.07e-04 | 211 | 22 | 3 | M12225 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 7.11e-04 | 47 | 22 | 2 | M1399 | |
| Coexpression | SMITH_LIVER_CANCER | 7.11e-04 | 47 | 22 | 2 | M18761 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN | 7.41e-04 | 48 | 22 | 2 | M1246 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 7.41e-04 | 48 | 22 | 2 | M10253 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 7.41e-04 | 48 | 22 | 2 | MM1088 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 7.56e-04 | 505 | 22 | 4 | M39167 | |
| Coexpression | LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE | 7.72e-04 | 49 | 22 | 2 | M2899 | |
| Coexpression | MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN | 8.41e-04 | 224 | 22 | 3 | M38981 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 9.66e-04 | 235 | 22 | 3 | M5311 | |
| Coexpression | LEE_LIVER_CANCER_CIPROFIBRATE_UP | 1.16e-03 | 60 | 22 | 2 | M2195 | |
| Coexpression | JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN | 1.16e-03 | 60 | 22 | 2 | M1515 | |
| Coexpression | LEE_LIVER_CANCER_DENA_UP | 1.16e-03 | 60 | 22 | 2 | M16524 | |
| Coexpression | FAN_OVARY_CL3_MATURE_CUMULUS_GRANULOSA_CELL_1 | 1.21e-03 | 254 | 22 | 3 | M41705 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 1.41e-03 | 268 | 22 | 3 | M45796 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | 1.53e-03 | 611 | 22 | 4 | M1106 | |
| Coexpression | KRAS.600_UP.V1_DN | 1.58e-03 | 279 | 22 | 3 | M2880 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.61e-03 | 71 | 22 | 2 | M3955 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 4.60e-06 | 445 | 22 | 6 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 5.09e-06 | 453 | 22 | 6 | GSM777067_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 5.22e-06 | 455 | 22 | 6 | GSM777055_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 5.99e-06 | 466 | 22 | 6 | GSM777050_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 2.68e-05 | 356 | 22 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500 | 5.51e-05 | 414 | 22 | 5 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 7.12e-05 | 437 | 22 | 5 | GSM777046_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 9.97e-05 | 768 | 22 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 1.06e-04 | 777 | 22 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#2_top-relative-expression-ranked_200 | 1.55e-04 | 18 | 22 | 2 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k2_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | 1.69e-04 | 846 | 22 | 6 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.73e-04 | 19 | 22 | 2 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_100 | 2.13e-04 | 21 | 22 | 2 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k3_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_200 | 2.79e-04 | 24 | 22 | 2 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_200 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 2.99e-04 | 320 | 22 | 4 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_100 | 3.03e-04 | 25 | 22 | 2 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.32e-04 | 132 | 22 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 4.46e-04 | 146 | 22 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 4.87e-04 | 364 | 22 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.01e-04 | 152 | 22 | 3 | ratio_MESO_vs_SC_1000_K1 | |
| CoexpressionAtlas | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1 | 7.06e-04 | 402 | 22 | 4 | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_200 | 7.80e-04 | 177 | 22 | 3 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_500 | 7.96e-04 | 415 | 22 | 4 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_500 | 8.03e-04 | 416 | 22 | 4 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_500 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.93e-04 | 428 | 22 | 4 | JC_hmvEC_1000_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.73e-04 | 191 | 22 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k4_1000 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 9.81e-04 | 439 | 22 | 4 | GSM777059_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 9.92e-04 | 773 | 22 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 1.13e-03 | 456 | 22 | 4 | GSM777032_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 1.16e-03 | 459 | 22 | 4 | GSM777037_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_1000 | 1.19e-03 | 805 | 22 | 5 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_500 | 1.22e-03 | 50 | 22 | 2 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.42e-03 | 54 | 22 | 2 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | 1.49e-03 | 847 | 22 | 5 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.87e-08 | 171 | 22 | 5 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.04e-08 | 174 | 22 | 5 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.35e-08 | 179 | 22 | 5 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-08 | 182 | 22 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.70e-08 | 184 | 22 | 5 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.85e-08 | 186 | 22 | 5 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.85e-08 | 186 | 22 | 5 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.92e-08 | 187 | 22 | 5 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.00e-08 | 188 | 22 | 5 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-08 | 188 | 22 | 5 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-08 | 188 | 22 | 5 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-08 | 188 | 22 | 5 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-08 | 188 | 22 | 5 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-08 | 188 | 22 | 5 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-08 | 188 | 22 | 5 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-08 | 190 | 22 | 5 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-08 | 190 | 22 | 5 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-08 | 192 | 22 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.33e-08 | 192 | 22 | 5 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | facs-Pancreas-Exocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-08 | 193 | 22 | 5 | c3161a14a40323a58aa202c8a1d6ea0e9c2b9814 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-08 | 196 | 22 | 5 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-08 | 196 | 22 | 5 | 5609b2d93172a488b35d854298a3a4e504e17e28 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-08 | 196 | 22 | 5 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-08 | 197 | 22 | 5 | 3332b9b5bf78f0203ebbd94257a36e9054d896c3 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.79e-08 | 197 | 22 | 5 | 78bc83cd5546c7dd128e6791acda97f55089bc1c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.79e-08 | 197 | 22 | 5 | 69d5b8588046d119b5dff9a7fd6f49e97e00a5b7 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.79e-08 | 197 | 22 | 5 | e6cbfa267eb2e05b441fd034786faae07bb0e081 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.89e-08 | 198 | 22 | 5 | 68ee0baa2f5cf239f2356cc59fee9041a7732bba | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.89e-08 | 198 | 22 | 5 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | distal-3-Endothelial-Bronchial_Vessel_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.89e-08 | 198 | 22 | 5 | 00fdee373eaa43c9ce897f2ba2ecbe94cedea93a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.99e-08 | 199 | 22 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-I_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.99e-08 | 199 | 22 | 5 | 5a002d49a8b84c158f7b4d7a3e78e6a937757bb7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.99e-08 | 199 | 22 | 5 | 1295f34a350bf48987e2fad411aaac3630efd3f1 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.99e-08 | 199 | 22 | 5 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-08 | 199 | 22 | 5 | 50abd20eb461927fde0ec5caae501d7f2277cf78 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 3.99e-08 | 199 | 22 | 5 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.99e-08 | 199 | 22 | 5 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.09e-08 | 200 | 22 | 5 | ca5401b76ab014080914bf78042d368cf318effa | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.09e-08 | 200 | 22 | 5 | 40286010bd17cf9e34ecd5440953b072ebfae208 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.09e-08 | 200 | 22 | 5 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 4.09e-08 | 200 | 22 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-08 | 200 | 22 | 5 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT1|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.09e-08 | 200 | 22 | 5 | 3a9633f5913f12b6865fc777c84f3f3ba795a78d | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.09e-08 | 200 | 22 | 5 | 70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.09e-08 | 200 | 22 | 5 | 444c72334df421375ae6fc69b0adfd4950d49a43 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.09e-08 | 200 | 22 | 5 | 5826c17da67bdaba3a828792279004218d8260c8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.24e-07 | 145 | 22 | 4 | 8da10bc6611976e1ec85e09f04a2dc5bf6555c9e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.07e-06 | 160 | 22 | 4 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.43e-06 | 172 | 22 | 4 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | Endothelial-A-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.43e-06 | 172 | 22 | 4 | a3201773a25832e92dd113fad165f1ecd37f5e91 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.43e-06 | 172 | 22 | 4 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.53e-06 | 175 | 22 | 4 | fed9e4120c758fdcc23bb248d1801002b0e0d485 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-06 | 175 | 22 | 4 | eb87275da6f61ecb4fbc89421dfd27bead1e0f48 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 176 | 22 | 4 | 3494ffa8555e6edf4b1250e10434bae9b73ec845 | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.57e-06 | 176 | 22 | 4 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.57e-06 | 176 | 22 | 4 | 2015539c58aa0bb118e111ffedd63dd9fe863bb1 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 176 | 22 | 4 | d43f6b7828b98e1dab7b726a5f99499d65a7db80 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-06 | 176 | 22 | 4 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.57e-06 | 176 | 22 | 4 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.60e-06 | 177 | 22 | 4 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-06 | 178 | 22 | 4 | f332c7a96844abecf05ca057480fbea9296688a2 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 1.68e-06 | 179 | 22 | 4 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-06 | 180 | 22 | 4 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.75e-06 | 181 | 22 | 4 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.79e-06 | 182 | 22 | 4 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.79e-06 | 182 | 22 | 4 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-06 | 183 | 22 | 4 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.83e-06 | 183 | 22 | 4 | 4617b18da8d699a44e4c47980197b1e7eb951470 | |
| ToppCell | Endothelial-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.83e-06 | 183 | 22 | 4 | 2c3f2c25c38f0598b4787d2ec335efe00fdc9751 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.83e-06 | 183 | 22 | 4 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.87e-06 | 184 | 22 | 4 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Pericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.87e-06 | 184 | 22 | 4 | 3d2d55d0f22874be21665ab37da710482f77fc36 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.87e-06 | 184 | 22 | 4 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | normal_Lung-Endothelial_cells-Tumor_ECs|normal_Lung / Location, Cell class and cell subclass | 1.87e-06 | 184 | 22 | 4 | 7ee98acda030366ac6cf3890a6d93fd0426712ed | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 185 | 22 | 4 | 742350093d90f96735dc73e3360cdd749bae63fd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-06 | 185 | 22 | 4 | 6da9a06e1514d5d5f47359a14637f02539846096 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-06 | 185 | 22 | 4 | 4a188e2566a75d1b4f3c879a8c241c277c4b451c | |
| ToppCell | Thalamus-Endothelial|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.95e-06 | 186 | 22 | 4 | dcc6e4417c4123d5ca6b96fa8ca4874626aaebdb | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.95e-06 | 186 | 22 | 4 | e8ead5634686ebaa6a230eea69795d923ce9939d | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-06 | 186 | 22 | 4 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-06 | 186 | 22 | 4 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 1.95e-06 | 186 | 22 | 4 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.95e-06 | 186 | 22 | 4 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-06 | 187 | 22 | 4 | f0c4d93f75615e570e4465fd622e3124189618a1 | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.99e-06 | 187 | 22 | 4 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-06 | 187 | 22 | 4 | 3ff57da09ed8394913fb683669d7bff84a936623 | |
| ToppCell | Endothelial-A-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.99e-06 | 187 | 22 | 4 | febe0b99a6a815ce687160a0e7af55228b1d5beb | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.99e-06 | 187 | 22 | 4 | be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-06 | 188 | 22 | 4 | be3d287ca60ec9b42be1a8eb0a9b911c16cd8c3a | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-06 | 188 | 22 | 4 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | IPF-Stromal-SMC|World / Disease state, Lineage and Cell class | 2.04e-06 | 188 | 22 | 4 | b66264e8f8d536ed2beec31e6746c687718f239b | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 188 | 22 | 4 | 1a3f95b4fd7611c634666761ddf21f1e58e56af8 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-06 | 188 | 22 | 4 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.04e-06 | 188 | 22 | 4 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-06 | 188 | 22 | 4 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | IPF-Stromal-SMC|IPF / Disease state, Lineage and Cell class | 2.04e-06 | 188 | 22 | 4 | e98b24c0de41285f01f7ac194ff0a1b59fd5c333 | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.04e-06 | 188 | 22 | 4 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-06 | 189 | 22 | 4 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.08e-06 | 189 | 22 | 4 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 189 | 22 | 4 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.14e-05 | 50 | 15 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PERICYTE_LIKE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.14e-05 | 50 | 15 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.14e-05 | 50 | 15 | 3 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_1 | |
| Computational | Keratin. | 5.79e-04 | 26 | 15 | 2 | MODULE_298 | |
| Computational | Genes in the cancer module 68. | 5.79e-04 | 26 | 15 | 2 | MODULE_68 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | 5.86e-04 | 835 | 15 | 6 | MODULE_88 | |
| Computational | Adrenal gland - metabolic genes. | 7.56e-04 | 314 | 15 | 4 | MODULE_19 | |
| Computational | Genes in the cancer module 3. | 1.60e-03 | 384 | 15 | 4 | MODULE_3 | |
| Computational | Trachea genes. | 2.13e-03 | 415 | 15 | 4 | MODULE_6 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.14e-03 | 50 | 15 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.14e-03 | 50 | 15 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.14e-03 | 50 | 15 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN | |
| Computational | Cell line expressed genes. | 2.47e-03 | 432 | 15 | 4 | MODULE_52 | |
| Computational | ECM and collagens. | 3.42e-03 | 225 | 15 | 3 | MODULE_47 | |
| Computational | Genes in the cancer module 55. | 4.28e-03 | 832 | 15 | 5 | MODULE_55 | |
| Drug | d-indobufen | 1.06e-09 | 50 | 22 | 5 | CID000044562 | |
| Drug | GK-101 | 3.77e-08 | 36 | 22 | 4 | CID000161853 | |
| Drug | AC1L1C2F | 5.92e-08 | 110 | 22 | 5 | CID000001711 | |
| Drug | Madecassol | 1.04e-07 | 46 | 22 | 4 | CID000108062 | |
| Drug | ridogrel | 1.72e-07 | 52 | 22 | 4 | CID005362391 | |
| Drug | NSC49633 | 1.86e-07 | 53 | 22 | 4 | CID000023340 | |
| Drug | AC1LAKND | 3.51e-07 | 62 | 22 | 4 | CID000470146 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 4.06e-07 | 314 | 22 | 6 | CID000447989 | |
| Drug | AC1L18QD | 4.97e-07 | 325 | 22 | 6 | CID000000213 | |
| Drug | BAPN | 6.09e-07 | 71 | 22 | 4 | CID000001647 | |
| Drug | malotilate | 6.09e-07 | 71 | 22 | 4 | CID000004006 | |
| Drug | AC1NMZ1B | 7.59e-07 | 75 | 22 | 4 | CID005034185 | |
| Drug | strontium ranelate | 8.44e-07 | 77 | 22 | 4 | CID006918182 | |
| Drug | benzyl nicotinate | 8.91e-07 | 2 | 22 | 2 | CID000007191 | |
| Drug | isobutoxy | 8.91e-07 | 2 | 22 | 2 | CID000010557 | |
| Drug | halofuginone lactate | 1.26e-06 | 85 | 22 | 4 | CID000062891 | |
| Drug | 4-hydroxyproline | 1.65e-06 | 91 | 22 | 4 | CID000000825 | |
| Drug | ticlopidine | 2.71e-06 | 103 | 22 | 4 | CID000005472 | |
| Drug | hydroxylysine | 3.40e-06 | 109 | 22 | 4 | CID000001029 | |
| Drug | PPACK | 3.93e-06 | 113 | 22 | 4 | CID003036757 | |
| Drug | AC1L9732 | 4.07e-06 | 114 | 22 | 4 | CID000439300 | |
| Drug | Tranilast sodium | 4.21e-06 | 115 | 22 | 4 | CID000005527 | |
| Drug | hyaluronan | 4.44e-06 | 263 | 22 | 5 | CID000024759 | |
| Drug | Selara | 5.87e-06 | 125 | 22 | 4 | CID000150310 | |
| Drug | DMSe | 7.28e-06 | 132 | 22 | 4 | CID000020796 | |
| Drug | pirfenidone | 8.68e-06 | 138 | 22 | 4 | CID000040632 | |
| Drug | DL-penicillamine | 8.93e-06 | 139 | 22 | 4 | CID000004727 | |
| Drug | PCR 4099 | 8.93e-06 | 139 | 22 | 4 | CID000002806 | |
| Drug | candesartan cilexetil | 1.06e-05 | 145 | 22 | 4 | CID000002540 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 1.63e-05 | 162 | 22 | 4 | CID000072363 | |
| Drug | 3-buten-1-ol | 1.87e-05 | 7 | 22 | 2 | CID000069389 | |
| Drug | khellin | 2.02e-05 | 171 | 22 | 4 | CID000003828 | |
| Drug | AC1L1DD6 | 2.42e-05 | 179 | 22 | 4 | CID000002299 | |
| Drug | thapsigargin; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.42e-05 | 179 | 22 | 4 | 7103_DN | |
| Drug | losartan | 2.56e-05 | 378 | 22 | 5 | CID000003961 | |
| Drug | LMWH | 2.99e-05 | 663 | 22 | 6 | CID000000772 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 2.99e-05 | 189 | 22 | 4 | CID000001413 | |
| Drug | foscarnet | 3.06e-05 | 190 | 22 | 4 | CID000003414 | |
| Drug | AC1L9MJT | 3.18e-05 | 192 | 22 | 4 | CID000448959 | |
| Drug | AC1L2FDK | 3.20e-05 | 9 | 22 | 2 | CID000020024 | |
| Drug | Nitrofurantoin [67-20-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 3.59e-05 | 198 | 22 | 4 | 4697_UP | |
| Drug | Domperidone maleate; Up 200; 7.4uM; MCF7; HT_HG-U133A | 3.66e-05 | 199 | 22 | 4 | 2655_UP | |
| Drug | chondroitin sulfate | 3.91e-05 | 413 | 22 | 5 | CID000024766 | |
| Drug | methyl nicotinate | 3.99e-05 | 10 | 22 | 2 | CID000007151 | |
| Drug | 3-methylbutoxy | 3.99e-05 | 10 | 22 | 2 | CID000012988 | |
| Drug | 2-amino-4,6-dinitrotoluene | 4.11e-05 | 70 | 22 | 3 | ctd:C035208 | |
| Drug | Fonofos | 4.52e-05 | 714 | 22 | 6 | ctd:D004397 | |
| Drug | 5-ethylphenazin-5-ium | 4.88e-05 | 11 | 22 | 2 | CID000082689 | |
| Drug | terbufos | 4.89e-05 | 724 | 22 | 6 | ctd:C012568 | |
| Drug | 2-heptanone | 5.85e-05 | 12 | 22 | 2 | CID000008051 | |
| Drug | AC1Q6PCP | 6.43e-05 | 230 | 22 | 4 | CID000005267 | |
| Drug | Vitallium | 8.09e-05 | 244 | 22 | 4 | ctd:D014800 | |
| Drug | prostacyclin sodium salt | 8.88e-05 | 250 | 22 | 4 | CID000000159 | |
| Drug | altanserin | 9.29e-05 | 15 | 22 | 2 | CID003033676 | |
| Drug | 3-deoxy-3-fluoro-D-glucose | 9.29e-05 | 15 | 22 | 2 | CID000450201 | |
| Drug | Parathion | 9.88e-05 | 822 | 22 | 6 | ctd:D010278 | |
| Drug | potassium nitrate | 1.06e-04 | 16 | 22 | 2 | CID000024434 | |
| Drug | moexipril | 1.06e-04 | 16 | 22 | 2 | CID000054889 | |
| Drug | NOC 18 | 1.06e-04 | 16 | 22 | 2 | ctd:C093285 | |
| Drug | bilirubin-phosphate | 1.06e-04 | 16 | 22 | 2 | CID005497144 | |
| Drug | K-11 | 1.20e-04 | 17 | 22 | 2 | CID000469667 | |
| Drug | dihydrotetrabenazine | 1.20e-04 | 17 | 22 | 2 | CID000123836 | |
| Drug | silibinin | 1.47e-04 | 285 | 22 | 4 | CID000005213 | |
| Drug | AC1NRCNR | 1.51e-04 | 19 | 22 | 2 | CID005289096 | |
| Drug | phenazine ethosulfate | 1.51e-04 | 19 | 22 | 2 | CID000082688 | |
| Drug | AC1NPJ0T | 1.68e-04 | 20 | 22 | 2 | CID005159168 | |
| Drug | teleocidin B | 2.20e-04 | 123 | 22 | 3 | CID000072425 | |
| Drug | Cholic Acids | 2.42e-04 | 127 | 22 | 3 | ctd:D002793 | |
| Drug | beta-damascenone | 2.43e-04 | 24 | 22 | 2 | ctd:C075388 | |
| Drug | 2,3-pentanedione | 2.53e-04 | 129 | 22 | 3 | ctd:C013186 | |
| Drug | sulfur mustard | 2.59e-04 | 130 | 22 | 3 | CID000010461 | |
| Drug | 2-pentanone | 2.64e-04 | 25 | 22 | 2 | CID000007895 | |
| Drug | homocysteine thiolactone | 2.65e-04 | 131 | 22 | 3 | CID000107712 | |
| Drug | mipafox | 2.86e-04 | 26 | 22 | 2 | CID000009738 | |
| Drug | 2-deoxy-2-fluoro-D-talose | 2.86e-04 | 26 | 22 | 2 | CID000068614 | |
| Drug | davidigenin | 3.81e-04 | 30 | 22 | 2 | CID000442342 | |
| Drug | KT 5823 | 3.81e-04 | 30 | 22 | 2 | ctd:C073601 | |
| Drug | 1yvf | 4.07e-04 | 31 | 22 | 2 | CID000657131 | |
| Drug | AC1Q5BXE | 4.34e-04 | 32 | 22 | 2 | CID000000037 | |
| Drug | colchine | 4.54e-04 | 383 | 22 | 4 | CID000002833 | |
| Drug | al-Badry | 5.20e-04 | 165 | 22 | 3 | CID000004545 | |
| Drug | mantATP | 5.20e-04 | 35 | 22 | 2 | CID000123756 | |
| Drug | I5B1 | 5.82e-04 | 37 | 22 | 2 | CID005487705 | |
| Drug | diketopiperazine | 6.46e-04 | 39 | 22 | 2 | CID000007817 | |
| Drug | balofloxacin | 7.50e-04 | 42 | 22 | 2 | CID000065958 | |
| Drug | AC1L1B5B | 7.86e-04 | 43 | 22 | 2 | CID000001289 | |
| Drug | Y-27632 | 7.90e-04 | 444 | 22 | 4 | CID000005711 | |
| Drug | 2,4-diacetylphloroglucinol | 8.23e-04 | 44 | 22 | 2 | CID000016547 | |
| Drug | Skimmianine [83-95-4]; Up 200; 15.4uM; HL60; HT_HG-U133A | 8.32e-04 | 194 | 22 | 3 | 2504_UP | |
| Drug | Nizatidine [76963-41-2]; Down 200; 12uM; HL60; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 3047_DN | |
| Drug | NSC3260 | 8.45e-04 | 195 | 22 | 3 | CID000220461 | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; HL60; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 2538_UP | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 4148_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 4281_UP | |
| Drug | Enoxacin [74011-58-8]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 5251_UP | |
| Drug | Nitrocaramiphen hydrochloride; Up 200; 10.8uM; MCF7; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 6504_UP | |
| Drug | Beta-sistosterol [83-46-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 4154_UP | |
| Drug | LS-63783 | 8.66e-04 | 804 | 22 | 5 | CID000000231 | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 4138_UP | |
| Drug | Hexestrol [84-16-2]; Up 200; 14.8uM; PC3; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 5776_UP | |
| Disease | Developmental Porencephaly | 4.82e-07 | 2 | 21 | 2 | C4082301 | |
| Disease | Post-traumatic Porencephaly | 4.82e-07 | 2 | 21 | 2 | C3698507 | |
| Disease | Congenital porencephaly | 4.82e-07 | 2 | 21 | 2 | C0302892 | |
| Disease | Porencephaly | 4.82e-07 | 2 | 21 | 2 | C4082173 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 4.82e-07 | 2 | 21 | 2 | C4551998 | |
| Disease | PORENCEPHALY, FAMILIAL | 4.82e-07 | 2 | 21 | 2 | C1867983 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 4.82e-07 | 2 | 21 | 2 | C3281105 | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 1.45e-06 | 3 | 21 | 2 | cv:C3281105 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 1.45e-06 | 3 | 21 | 2 | 614519 | |
| Disease | myopathy (implicated_via_orthology) | 5.26e-06 | 48 | 21 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | FEV/FEC ratio | 1.48e-05 | 1228 | 21 | 7 | EFO_0004713 | |
| Disease | collagen disease (implicated_via_orthology) | 3.17e-05 | 12 | 21 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | Nephrotic Syndrome | 1.68e-04 | 27 | 21 | 2 | C0027726 | |
| Disease | Cerebral Hemorrhage | 1.80e-04 | 28 | 21 | 2 | C2937358 | |
| Disease | spontaneous coronary artery dissection | 2.22e-04 | 31 | 21 | 2 | EFO_0010820 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 6.50e-04 | 53 | 21 | 2 | C4707243 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGNTGPYGLVGVPGC | 111 | Q01955 | |
| VGPQGYNGPPGLQGF | 66 | P08572 | |
| PGVVNIVPGYGPTAG | 216 | P00352 | |
| QSYGGGPAQVPLPGG | 111 | P20073 | |
| GSPGCVPYPENGIGG | 441 | Q9UBL0 | |
| EPGYPGLIGRQGPQG | 306 | P02462 | |
| GYTNGIVECQPGPPG | 426 | P02462 | |
| PGYEGNPIQPGGKCR | 856 | P98160 | |
| AGGPCVGGLPPYATF | 716 | Q6GQQ9 | |
| CQGTPGIPEGPYSEG | 131 | Q6Y2X3 | |
| QPCGGPGLAPGVRSY | 231 | Q96S86 | |
| KGGPGFPVCPAGGIQ | 96 | P19013 | |
| GGYGPVCPPGGIQEV | 141 | P04264 | |
| GPQGPPGIGYEGRQG | 1386 | P39060 | |
| QYEGPGFCGPLAPGT | 1871 | Q9Y6R7 | |
| EQYEGPGFCGPLAPG | 3071 | Q9Y6R7 | |
| VPGPQGPSGQPGYCD | 1746 | Q05707 | |
| DPGYQPTPGGGCQDV | 1036 | Q8N2S1 | |
| PGCPTGYLGPGGIGD | 441 | Q68CP4 | |
| GCGLGQELLPGVYPG | 391 | Q8NBF1 | |
| PYAGAGPLVGVPGVG | 301 | Q6ZRV2 | |
| PYPGSQAPGQIGGVV | 1521 | Q8TDX9 | |
| PGYPSVPPTGGCGEG | 246 | A8MPS7 | |
| GFGPYCPPGGIQEVT | 126 | Q7Z794 |